Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Dihydroergocristine is an alkaloid with diverse biological activities.1,2,3,4 It inhibits contraction of isolated rat vas deferens induced by norepinephrine (pA2 = 7.88) but not calcium.1 Dihydroergocristine (0.1-100 µg/kg, i.v.) reduces blood pressure in a rat model of norepinephrine-induced hypertension and increases blood pressure in hypotensive rats.2 It reduces aqueous humor production and intraocular pressure in a rabbit model of α-chymotrypsin-induced ocular hypertension.3 Dihydroergocristine also reduces hypermotility induced by ethanol in mice.4
WARNING This product is not for human or veterinary use.
1. Dualism in the α-
2. Effects of phentolamine, dihydroergocristine and isoxsuprine on the blood pressure and heart rate in normotensive, hypotensive and hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 290(4), 335-346 (1975).
3. The effect of topical dihydroergocristine on the intraocular pressure in alpha-
4. Inhibitory effect of dihydroergocristine, phenoxybenzamine and propranolol on the hypermotility induced by low doses of ethyl alcohol in mice. Arch. Farmacol. Toxicol. 5(2), 117-122 (1979).